INJ Price Prediction: Momentum Flatlines Below Short-Term MAs as Sell Volume Takes Control
Injective fell 2.35% over the past 24 hours to $7.55 on Binance spot, trading below all four short-term moving averages while the MACD histogram converges to zero and taker sell volume outpaces buy......
Asanat Analysis — Why it matters
Injective's technical deterioration—trading below short-term MAs with MACD convergence and sell-volume dominance—signals weakening conviction among active traders. This pattern typically precedes either capitulation selling or consolidation, but doesn't indicate fundamental breakdown. The $7.55 level matters primarily as a support test; breach below would expose deeper technical structure.
INJ's momentum flatline occurs amid broader market conditions. Injective has positioned itself as infrastructure for cross-chain derivatives and exchange protocols; technical weakness here doesn't impair those primitives, but does reflect decreased speculative appetite. Watch whether institutional builders maintain development velocity or defer ecosystem initiatives during this price compression phase.
Short-term sell pressure often creates entries for longer-duration holders, but the article's framing—emphasizing taker volume imbalance—suggests this may be retail liquidation cascades rather than structural repositioning by informed participants. Volume analysis matters more than price action alone for distinguishing signal from noise.